Overview


According to FutureWise analysis the market for human milk oligosaccharides (HMO) in 2023 is US$ 0.23 billion, and is expected to reach US$ 1.22 billion by 2031 at a CAGR of 22.92%.

Human Milk Oligosaccharides are a type of complex carbohydrate that is found naturally in human breast milk. They are composed of a chain of simple sugar molecules and are highly diverse, with over 200 different types of HMOs identified to date. HMOs are not present in cow's milk or infant formula, and their unique composition has been shown to have several health benefits for infants. HMOs serve as a source of nourishment for beneficial bacteria in the gut rather than being digested by the infant's digestive system. They can promote the growth of specific types of bacteria, such as Bifidobacteria, which are associated with improved gut health and a stronger immune system. HMOs have also been shown to prevent harmful bacteria, such as Salmonella and E. coli, from binding to the gut lining and causing infections.

In addition to their effects on gut health, HMOs have also been linked to reduced risk of allergies and infections in infants. They may also have potential therapeutic applications in the treatment and prevention of certain diseases, such as inflammatory bowel disease and necrotizing enterocolitis. HMOs are difficult to synthesize and must be extracted from human breast milk, which can be a limiting factor in their availability and affordability. However, there is growing interest in incorporating HMOs into infant formula and other food and beverage products as an alternative to breast milk.

FutureWise Market Research has published a report that provides an insightful analysis of Human Milk Oligosaccharides Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Human Milk Oligosaccharides Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Inbiose
  • Elicityl Sa
  • Jennewein Biotechnologie
  • Glycom
  • Zuchem
  • Dextra Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Human Milk Oligosaccharides Market:

  • In August 2021, Nestle introduced its latest NAN SUPREME PRO 3 formula products containing five human milk oligosaccharides that the company claims strengthen children's immune systems.

The human milk oligosaccharides market is anticipated to experience substantial expansion in the coming years, driven by several key dynamics. One of the primary drivers of the HMO market is the growing awareness of the health benefits of HMOs. HMOs are complex carbohydrates present naturally in breast milk and are not present in cow's milk or infant formula. They've been found to encourage the growth of helpful bacteria in the gut, which can improve the immune system and lower the risk of illnesses and allergies in infants. This has increased the demand for HMOs as an ingredient in infant formula and other food and beverage products. Another factor driving the growth of the HMO market is the increasing prevalence of breastfeeding difficulties. While breast milk is the preferred source of nutrition for infants, some mothers may have difficulty producing sufficient milk or may be unable to breastfeed for other reasons. In these cases, HMOs can be added to infant formula to provide some of the benefits of breast milk.

However, the human milk oligosaccharides market is also subject to a number of challenges and restraints that may impact its growth in the future. One of the key restraints is the high cost of production. HMOs are complex sugars that are difficult to synthesize and must be extracted from human breast milk, which can be expensive and difficult to obtain in large quantities. This has limited the availability of HMOs and has made them relatively expensive compared to other types of ingredients.

By Product Type

  • Neutral
  • Acidic
  • Others

By Application

  • Infant formula
  • Functional Food And Beverages
  • Food Supplements
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia-Pacific region dominates the global market. A sizeable portion of the market is accounted by Asia-Pacific, where the infant formula and nutritional beverage industries are increasing rapidly, the dairy sector is growing, and the product line is experiencing fast technical improvements. Additionally, shifts in eating habits that emphasise healthy foods are probably going to result in a rise in demand for goods. The market for human milk oligosaccharides is anticipated to expand across the region during the course of the forecast period due to the prebiotic qualities of HMO, which support the development of beneficial bacteria, as well as the rising demand for functional foods and dietary supplements for improved health and digestion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Human Milk Oligosaccharides (HMO) Market By Product Type, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Human Milk Oligosaccharides (HMO) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Human Milk Oligosaccharides (HMO) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Human Milk Oligosaccharides (HMO) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Human Milk Oligosaccharides (HMO) Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Neutral
        2. Acidic
        3. Others

  • 8.   Human Milk Oligosaccharides (HMO) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Infant formula
        2. Functional Food And Beverages
        3. Food Supplements
        4. Others

  • 9.   North America Human Milk Oligosaccharides (HMO) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Human Milk Oligosaccharides (HMO) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Human Milk Oligosaccharides (HMO) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Human Milk Oligosaccharides (HMO) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Human Milk Oligosaccharides (HMO) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Inbiose
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Elicityl Sa
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Jennewein Biotechnologie
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Glycom
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Zuchem
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Dextra Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients